Autopsy report · NCT01695759
Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.
Cause of deathNo reason given
Life of this trial
- Registered 1 year 3 months before it started.
- Ran for about 4 years 1 month before it stopped.
- 92 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Azidus Brasil
- Sponsor type
- Industry
- Conditions
- Chronic Kidney Disease; Anemia
- Interventions
- Epoetin alpha; Eprex
- Participants
- 92
- Sites
- 10
- Countries
- Brazil
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.